Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Dicerna, Roche, RXi, and More

Premium

Title: Compositions and Methods for Immunostimulatory RNA Oligonucleotides

Patent Number: 8,815,503

Filed: Sept. 14, 2006

Lead Inventor: Gunther Hartmann, University of Bonn


Title: Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells

Patent Number: 8,815,505

Filed: Sept. 30, 2010

Lead Inventor: Sebastien Couillard-Despres, Roche


Title: Modulation of Gene Expression Using Oligomers that Target Gene Regions Downstream of 3' UTR Regions

Patent Number: 8,815,586

Filed: April 23, 2010

Lead Inventor: David Corey, University of Texas


Title: Phagocytic Cell Delivery of RNAi

Patent Number: 8,815,818

Filed: July 17, 2009

Lead Inventor: Dmitry Samarsky, RXi Pharmaceuticals


Title: Antiviral Therapy

Patent Number: 8,815,820

Filed: March 30, 2010

Inventor: Amy Buck, University of Edinburgh


Title: Double-stranded Oligonucleotides

Patent Number: 8,815,821

Filed: Oct. 20, 2011

Inventor: Tod Woolf, Life Technologies


Title: Methods and Compositions for the Specific Inhibition of Beta-catenin by Double-stranded RNA

Patent Number: 8,815,825

Filed: Dec. 18, 2012

Lead Inventor: Bob Brown, Dicerna Pharmaceuticals


Title: Anti-microRNA Oligonucleotide Molecules

Patent Number: 8,816,060

Filed: Nov. 13. 2012

Lead Inventor: Thomas Tuschl, Rockefeller University


Title: Method to Trigger RNA Interference

Patent Number: 8,816,061

Filed: March 14, 2013

Lead Inventor: James Carrington, Oregon State University

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.